KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Current Liabilities (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Total Current Liabilities for 17 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 5.03% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 5.03% year-over-year, with the annual reading at $2.3 billion for FY2025, 5.03% up from the prior year.
  • Total Current Liabilities hit $2.3 billion in Q4 2025 for Quest Diagnostics, up from $2.1 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $2.3 billion in Q1 2024 to a low of $1.4 billion in Q1 2023.
  • Historically, Total Current Liabilities has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2021.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 69.59% in 2024 and later tumbled 37.29% in 2025.
  • Year by year, Total Current Liabilities stood at $1.8 billion in 2021, then fell by 11.52% to $1.6 billion in 2022, then rose by 17.02% to $1.8 billion in 2023, then increased by 19.5% to $2.2 billion in 2024, then grew by 5.03% to $2.3 billion in 2025.
  • Business Quant data shows Total Current Liabilities for DGX at $2.3 billion in Q4 2025, $2.1 billion in Q3 2025, and $2.0 billion in Q2 2025.